Headlines
-
GlucaGen HypoKit recall
Thursday | Sep 8 2016Novo Nordisk has alerted pharmacists about the recall of four batches of its GlucaGen HypoKit in Australia, after an investigation found a small number of needles were detached from the pre-filled syringes in the products.
-
Sigma profit surges 15.5%
Thursday | Sep 8 2016Sigma Pharmaceuticals this morning released its figures for the six months to 31 Jul, with ceo Mark Hooper saying the results reflect the company's strategic positioning to "broaden the business and drive operational improvement".
-
Priceline backs female AFL
Wednesday | Sep 7 2016Priceline Pharmacy has been named as a co-major sponsor of the Western Bulldogs' team in the newly formed women's Australian Football League.
-
CMA prevention priority
Wednesday | Sep 7 2016Complementary Medicines Australia (CMA) says the use and further development of complementary medicines "provides an opportunity to counteract spiralling health care costs through more effective disease prevention and preventable chronic disease management".
-
UK pharmacy cuts delayed
Wednesday | Sep 7 2016The proposed 170 million reduction in pharmacy funding in England will be postponed beyond next month, according to UK pharmacy minister David Mowat.
-
SHPA Residency release
Tuesday | Sep 6 2016The Society of Hospital Pharmacists has announced that from next week it will open applications for sites wanting to be accredited in the first phase of an SHPA Residency Program in 2017.
-
Chemmart catalogue coup
Tuesday | Sep 6 2016Chemmart is celebrating after taking out the Health and Wellbeing category at the Catalogue Awards last week.
-
Pharmacists key, urges RPS
Tuesday | Sep 6 2016Britain's Royal Pharmaceutical Society (RPS) has reaffirmed the importance of pharmacist care for patients, with president Martin Astbury telling attendees at the RPS annual conference last weekend that "a pharmacy without a pharmacist is a shop".
-
90 Review consultations
Tuesday | Sep 6 2016The panel conducting the government's Review of Pharmacy Remuneration and Regulation has held more than 90 site visits and consultations across the country over the last five weeks.
-
FDA tightens opioid labels
Monday | Sep 5 2016Following a review of the evidence, the US Food and Drug Administration (FDA) has announced that it is requiring class-wide changes to drug labelling, including patient information, to help inform health care providers and patients of the serious risks associated with the combined use of certain opioid medications and benzodiazepines.